Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter financial results on Thursday, May 8, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call by phone may do so by di...
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy. Mr. Ditto will report to Michael Dale, President, and Chief Executive Officer, and will lead the development of...
NEW YORK--(BUSINESS WIRE)-- Coty Inc. (Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced the conclusion of its partnership with Kim Kardashian and the SKKN by Kim (“SKKN”) brand, with the closing of the sale of its 20% stake in the brand to SKIMS. Following the transaction, SKIMS will be uniting the beauty and lifestyle ventures under one brand. Anna von Bayern, CEO of Kylie Cosmetics and leader of Kim Kardashian’s beauty business at Coty, says: “Since Coty’s establishment over 120 years ago, we have remained at the forefront of consumer innovation. We are the go-...
NEW YORK--(BUSINESS WIRE)-- Coty (NYSE : COTY) (Paris : COTY), l’une des plus grandes entreprises de beauté au monde, possédant un portefeuille emblématique de marques dans les domaines du parfum, du maquillage, du soin de la peau et du corps, a organisé une afin de discuter des définitions restrictives de la beauté. Dans le cadre du nouveau chapitre de la campagne primée #UndefineBeauty, le panel déconstruit les mythes liés à la beauté et intègre des perspectives issues des neurosciences, de l’art, des réseaux sociaux, de la sociologie et de la santé mentale, mettant en avant la nécessité d’...
NEW YORK--(BUSINESS WIRE)-- Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, skin and body care, hosted a to discuss restrictive beauty ideals and definitions. As the next chapter of the award-winning #UndefineBeauty campaign, the panel debunks beauty myths and includes perspectives on neuroscience, art, social media, sociology, and mental health, and underscores the need for collective action to drive change. This press release features multimedia. View the full release here: Coty #UndefineBeau...
89bio to Participate in the Leerink Partners Global Healthcare Conference SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s Management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025 at 4:20 PM EST and participate in one-on-one investor meetings. The webcast of th...
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates – ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials in patients with non-cirrhotic (F2-F3) and compensated cirrhotic (F4) metabolic dysfunction-associated steatohepatitis (MASH) continue to advance with topline histology data expected in 1H 2027 and 2028, respectively – –The Phase 3 ENTRUST trial in severe hypertriglyceridemia (SHTG) will be unblinded after study completion at Week 52 vs. Week 26 following discussions with the U.S. Food and Drug Administration (FDA); topline data are now expec...
MURFREESBORO, Tenn.--(BUSINESS WIRE)-- (NYSE American: ), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2024 totaled $1,307,382,000 compared to $1,141,544,000 for the year ended December 31, 2023, an increase of 14.5%. The increase in net operating revenues for the 2024 year compared to the 2023 year was due to a 9.4% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Manor (“White Oak”). The White Oak operations consist of 22 healthca...
Axogen, Inc. To Host Analyst & Investor Day on March 4th ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will hold its Analyst & Investor Day on March 4, 2025, between 9am-12pm Eastern. Featured speakers will include Chief Executive Officer - Michael Dale, Chief Financial Officer - Nir Naor, and other senior members of the leadership team. During the event, the Axogen team will offer an overview of the business, strategic initiatives and g...
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Financial Results and Business Highlights Fourth quarter revenue was $49.4 million, a 15.1% increase compared to the fourth quarter of 2023.Gross margin was 76.1% for the fourth ...
NEW YORK--(BUSINESS WIRE)-- Regulatory News: Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, is pleased to confirm that Chief Executive Officer Sue Nabi and Chief Financial Officer Laurent Mercier will present at the 2025 Consumer Analyst Group of New York Conference (CAGNY) on Wednesday, February 19 at 4:00pm EST or 10:00pm CET. Coty will provide an update on its category leadership, financial and strategic progress, and how it plans to fuel outperformance of the beauty ...
MURFREESBORO, Tenn.--(BUSINESS WIRE)-- (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 61 cents per common share to shareholders of record on March 28, 2025 and payable on April 25, 2025. Forward-Looking Statements Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from...
Moody's Ratings (Moody's) today upgraded Coty Inc.'s ("Coty") Corporate Family Rating ("CFR") to Ba1 from Ba2, its Probability of Default Rating to Ba1-PD from Ba2-PD, the company's senior secured first lien revolving credit facility rating to Ba1 from Ba2, the senior secured notes ratings to Ba1 fr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.